Insider Transactions in Q1 2023 at Organogenesis Holdings Inc. (ORGO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
Michele Ilene Korfin Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+42.31%
|
-
|
|
Feb 22
2023
|
Gilberto Quintero Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+42.31%
|
-
|
|
Feb 22
2023
|
Prathyusha Duraibabu Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+40.24%
|
-
|
|
Feb 22
2023
|
Gary S. Gillheeney President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
896,414
+33.56%
|
-
|
|
Feb 22
2023
|
David Francisco Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
242,508
+45.38%
|
-
|
|
Feb 22
2023
|
Patrick Bilbo Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
327,386
+39.33%
|
-
|
|
Feb 22
2023
|
Brian Grow Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
291,009
+43.72%
|
-
|
|
Feb 22
2023
|
Lori Freedman Chief Admin. and Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
278,884
+44.61%
|
-
|
|
Feb 22
2023
|
Antonio S. Montecalvo Vice President, Health Policy |
BUY
Grant, award, or other acquisition
|
Direct |
99,428
+41.7%
|
-
|
|
Feb 22
2023
|
Arthur S Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+32.49%
|
-
|
|
Feb 22
2023
|
Jon L Giacomin Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+41.78%
|
-
|
|
Feb 22
2023
|
Michael Joseph Driscoll Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,737
+41.87%
|
-
|
|
Feb 16
2023
|
Brian Grow Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-0.95%
|
$1,598
$2.75 P/Share
|
|
Feb 16
2023
|
Lori Freedman Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
765
-1.12%
|
$1,530
$2.75 P/Share
|
|
Feb 16
2023
|
Antonio S. Montecalvo Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-1.78%
|
$1,434
$2.75 P/Share
|
|
Feb 16
2023
|
Gary S. Gillheeney President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,787
-0.43%
|
$7,574
$2.75 P/Share
|
|
Feb 16
2023
|
David Francisco Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-1.89%
|
$1,906
$2.75 P/Share
|
|
Feb 16
2023
|
Patrick Bilbo Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
936
-0.52%
|
$1,872
$2.75 P/Share
|
|
Feb 15
2023
|
Brian Grow Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,346
-3.81%
|
$6,692
$2.92 P/Share
|
|
Feb 15
2023
|
Lori Freedman Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,635
-5.06%
|
$7,270
$2.92 P/Share
|
|
Feb 15
2023
|
Antonio S. Montecalvo Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,249
-3.01%
|
$2,498
$2.92 P/Share
|
|
Feb 15
2023
|
Gary S. Gillheeney President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,517
-2.38%
|
$43,034
$2.92 P/Share
|
|
Feb 15
2023
|
David Francisco Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,506
-6.51%
|
$7,012
$2.92 P/Share
|
|
Feb 15
2023
|
Patrick Bilbo Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,599
-2.51%
|
$9,198
$2.92 P/Share
|